# Rivermount VC Fund

Rivermount VC Fund is a Private Equity based in San Francisco, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** www.rivermt.com
- **LinkedIn:** https://www.linkedin.com/company/rivermount

## Regulatory record

- **Reports private funds:** No

## About

Rivermount VC Fund is a venture capital firm founded in 2018 in California, United States. The firm focuses on investment management in high tech and healthcare sectors. It offers investment opportunities and asset management services to high-net-worth families.

## Sectors

- Healthcare Services
- Enterprise Software

## People

- Deborah Lynch — Co-Founder
- Ted Powell — Co-Founder
- Theresa Metz — Senior Consultant

## Questions

### What is Rivermount's investment strategy?

Rivermount says it seeks early-stage opportunities in high-tech and healthcare for high-net-worth families. The disclosed portfolio is heavily weighted toward therapeutics and medical devices, with positions in RNA therapies, digital PCR, neuromodulation, and diagnostics. The firm targets asset appreciation through technological innovation and does not publicly discuss stage cutoffs, check sizes, or reserve strategies.

### How is Rivermount structured — is it a pure venture fund or a hybrid?

Rivermount operates a venture fund alongside Rivermount Management LLC, a consulting entity that provides portfolio management, financial planning, and alternative-investment advice. This dual structure means the firm both deploys capital into its own venture deals and advises the same high-net-worth families on their broader asset allocations.

### Does Rivermount participate in fund commitments or only direct deals?

The firm's website only details direct company investments and does not mention fund-of-fund commitments. Its portfolio list is entirely composed of named operating companies in biotech and healthcare, and there is no reference to allocations to external venture managers.

### Is there a pre-Rivermount track record attributable to the team?

Yes. The firm's website distinguishes a section labeled 'Portfolio of the Team Before Founding the Fund' that includes Flexus Biosciences, acquired by Bristol Myers Squibb, and Arcus Biosciences, which completed an IPO in 2018. These deals are not part of Rivermount's formal fund vehicle but indicate the principals' prior investment activity.

## Related profiles

- [Riverland Wealth Management](https://altss.com/profile/riverland-wealth-management)
- [RiverPark Capital](https://altss.com/profile/riverpark-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/rivermount-vc-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology